Back |
home / stock / phio / phio message board
Subject | By | Source | When |
---|---|---|---|
Jake13: RXII Stock year to date has changed -18.75% percent. +0.78% in the last 30 days. $RXII Rxi P | Jake13 | investorshangout | 03/10/2015 7:50:19 AM |
chartguy89: RXII 1.30 Rxi Pharmaceuticals Stock Charts $RXII Last Updated: 03/09/15 Last price: 1.30 | chartguy89 | investorshangout | 03/10/2015 7:19:57 AM |
danrocks: RXII Stock is number 27 for the largest percentage gain out of 250 stocks. $RXII RXII is u | danrocks | investorshangout | 11/28/2014 3:45:41 PM |
clayton: RXII 2.12 Rxi Pharmaceuticals $RXII stock added to my watch list. Right now with RXII I am | clayton | investorshangout | 11/28/2014 2:49:48 PM |
Jake13: RXII Stock year to date has changed -25.52% percent. +4.85% in the last 30 days. $RXII Rxi P | Jake13 | investorshangout | 11/27/2014 12:06:57 PM |
News, Short Squeeze, Breakout and More Instantly...
Phio Pharmaceuticals Corp. Company Name:
PHIO Stock Symbol:
NASDAQ Market:
Phio Pharmaceuticals Corp. Website:
Marlborough, Massachusetts--(Newsfile Corp. - July 12, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) (the "Company"), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells...
Five sites across the U.S. are now participating in the Phase 1b study Marlborough, Massachusetts--(Newsfile Corp. - July 8, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to ...
Marlborough, Massachusetts--(Newsfile Corp. - July 5, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells, today announced i...